Private Capital Group’s Medicines Co MDCO Stock Holding History

Private Capital Group’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50	Closed	-$4K	–	2239
2019 Q4	$4K	Sell	50 -310	-86%	-$20.7K	﹤0.01%	1584
2019 Q3	$18K	Buy	360 +299	+490%	+$11.9K	﹤0.01%	1248
2019 Q2	$2K	Buy	+61	New	+$1.99K	﹤0.01%	1951
2018 Q3	–	Sell	-61	Closed	-$2K	–	2346
2018 Q2	$2K	Sell	61 -146	-71%	-$4.74K	﹤0.01%	1945
2018 Q1	$7K	Buy	207 +12	+6%	+$375	﹤0.01%	1519
2017 Q4	$5	Buy	+195	New	+$6.01K	﹤0.01%	1670

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Private Capital Group's MDCO Position: Q1 2020 in Review

Private Capital Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 50 shares — an estimated $4K sold.

Private Capital Group first reported a position in MDCO in Q4 2017 and held it in 6 quarters. The position peaked at $18K in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Private Capital Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Private Capital Group sold 50 Medicines Co shares in Q1 2020, an estimated $4K.
Private Capital Group first reported a position in Medicines Co in Q4 2017 and held it in 6 quarters.
Private Capital Group's Medicines Co position peaked at $18K in Q3 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Private Capital Group's 13F filing for Q1 2020, filed 7 May 2020.